Schering filed suit against Actavis over a patent related to combinations of hydroxyl-substituted azetidinone hypercholesterolemic agents. 10/13, District of New Jersey, 2:2011cv06067.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.
